Illumina Granted Review in Patent Litigation Against Complete Genomics

Illumina ILMN announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California granted Illumina's request to file a motion seeking reconsideration of the Court's October 16, 2012 ruling invalidating certain claims of U.S. Patent No. 6,306,597, which is being asserted by Illumina against Complete Genomics, Inc. Under Judge Laporte's order, Illumina is permitted to file briefing asking the Court to reconsider its earlier ruling invalidating claims 14 and 15 of the ‘597 patent. Illumina will seek a January 8, 2013 hearing date on the motion for reconsideration. Jay Flatley, Illumina's President and CEO, stated, “We are very pleased that the Court has agreed to review See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceContractsManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!